Both can also be synthesised locally in the mammary gland (Clevenger et al, 1995; Reynolds et al, 1997), and antagonists of the prolactin and growth hormone (GH) receptors are able to inhibit proliferation of breast cancer lines (Fuh and Wells, 1995). The gene discussed is PRL; the disease is breast cancer.